Standard BioTools Inc. (LAB)
NASDAQ: LAB · IEX Real-Time Price · USD
2.190
+0.010 (0.46%)
At close: Jul 19, 2024, 4:00 PM
2.170
-0.020 (-0.91%)
Pre-market: Jul 22, 2024, 9:09 AM EDT
Standard BioTools Employees
As of December 31, 2023, Standard BioTools had 539 total employees, including 534 full-time and 5 part-time employees. The number of employees increased by 16 or 3.06% compared to the previous year.
Employees
539
Change (1Y)
16
Growth (1Y)
3.06%
Revenue / Employee
$235,178
Profits / Employee
-$252,289
Market Cap
811.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
The Pennant Group | 5,791 |
CureVac | 1,172 |
Atrion | 712 |
Cytek Biosciences | 676 |
Clover Health Investments | 552 |
Cogent Biosciences | 164 |
Mesoblast | 83 |
Olema Pharmaceuticals | 74 |
LAB News
- 5 days ago - Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024 - GlobeNewsWire
- 7 weeks ago - Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers - GlobeNewsWire
- 2 months ago - Standard BioTools to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Standard BioTools Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth - GlobeNewsWire
- 3 months ago - Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging - GlobeNewsWire
- 3 months ago - Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research - GlobeNewsWire